ASKA Pharmaceutical Holdings Co.,Ltd.
| Market Cap | 62.8B |
| P/E Ratio | 13.16 |
| P/B Ratio | 0.91 |
| EPS | 179.95 |
| Dividend Yield | - |
| D/E Ratio | 0.45 |
| Current Ratio | 2.54 |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Currency | JPY |
Business Overview
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | PHARMACEUTICAL |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | ASKA Pharmaceutical Holdings Co.,Ltd. |
| Ticker | 4886 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Fiscal Year | 2025 |
| Currency | JPY |
| Market Cap | 62.8B |
| Revenue | 64.1B |
| Net Income | 5.1B |
| P/E Ratio | 13.16 |
| EPS | 179.95 |
| Net Margin | 8.0% |
| ROE | 7.4% |
| Dividend Yield | - |
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.